Article Details
Retrieved on: 2025-03-31 21:57:53
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
D., CEO and Director of Connect Biopharma (CNTB). “We are on track to initiate parallel Phase 2 trials of rademikibart as an adjunct to standard of ...
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here